Boryung Pharmaceutical Co., Ltd. (KOSE:A003850) announces a share repurchase program. Under the program, the company will repurchase up to KRW 10,000 million worth of its shares pursuant to a contract with HANWHA INVESTMENT & SECURITIES CO., LTD. The purpose of the program is to improve shareholder value and to stabilize stock price. The program will expire on April 1, 2022. As of November 8, 2020, the company had 2,102,075 shares in treasury within scope available for dividend and had 57,835 shares in treasury through other repurchase.